Jortani SA - Search Results

1

The journey to regulation of protein-based multiplex quantitative assays.

Boja ES, Jortani SA, Ritchie J, Hoofnagle AN, Težak Ž, Mansfield E, Keller P, Rivers RC, Rahbar A, Anderson NL, Srinivas P, Rodriguez H. Boja ES, et al. Among authors: jortani sa. Clin Chem. 2011 Apr;57(4):560-7. doi: 10.1373/clinchem.2010.156034. Epub 2011 Feb 7. Clin Chem. 2011. PMID: 21300740

2

Proteomics: a new diagnostic frontier.

Hortin GL, Jortani SA, Ritchie JC Jr, Valdes R Jr, Chan DW. Hortin GL, et al. Among authors: jortani sa. Clin Chem. 2006 Jul;52(7):1218-22. doi: 10.1373/clinchem.2006.067280. Epub 2006 May 4. Clin Chem. 2006. PMID: 16675505

3

Strategies for developing biomarkers of heart failure.

Jortani SA, Prabhu SD, Valdes R Jr. Jortani SA, et al. Clin Chem. 2004 Feb;50(2):265-78. doi: 10.1373/clinchem.2003.027557. Epub 2003 Dec 4. Clin Chem. 2004. PMID: 14656906 Review.

4

Improved sensitivity for methotrexate analysis using enzyme multiplied immunoassay technique on the Siemens Viva-E instrument.

Borgman MP, Hiemer MF, Molinelli AR, Ritchie JC, Jortani SA. Borgman MP, et al. Among authors: jortani sa. Ther Drug Monit. 2012 Apr;34(2):193-7. doi: 10.1097/FTD.0b013e31824b93a5. Ther Drug Monit. 2012. PMID: 22377747

5

Multicenter evaluation of analytical characteristics of the Elecsys^® Periostin immunoassay.

Palme S, Christenson RH, Jortani SA, Ostlund RE, Kolm R, Kopal G, Laubender RP. Palme S, et al. Among authors: jortani sa. Clin Biochem. 2017 Feb;50(3):139-144. doi: 10.1016/j.clinbiochem.2016.10.002. Epub 2016 Oct 8. Clin Biochem. 2017. PMID: 27725167 Free article.

6

Convergence of three methods to resolve discrepant immunoassay digitoxin results.

Jortani SA, Trepanier D, Yatscoff RW, Valdes R Jr. Jortani SA, et al. Clin Chem. 1997 Sep;43(9):1805-8. Clin Chem. 1997. PMID: 9299991 No abstract available.

7

Genotyping three SNPs affecting warfarin drug response by isothermal real-time HDA assays.

Li Y, Jortani SA, Ramey-Hartung B, Hudson E, Lemieux B, Kong H. Li Y, et al. Among authors: jortani sa. Clin Chim Acta. 2011 Jan 14;412(1-2):79-85. doi: 10.1016/j.cca.2010.09.014. Epub 2010 Sep 18. Clin Chim Acta. 2011. PMID: 20854800 Free PMC article.

8

An overview of a recent court challenge to the protection of biomarkers as intellectual property.

Hall SC, Tromp JM, Jortani SA. Hall SC, et al. Among authors: jortani sa. Clin Chim Acta. 2011 May 12;412(11-12):802-5. doi: 10.1016/j.cca.2011.01.024. Epub 2011 Feb 20. Clin Chim Acta. 2011. PMID: 21315704 Review.

9

Reference intervals of urinary acute kidney injury (AKI) markers [IGFBP7]∙[TIMP2] in apparently healthy subjects and chronic comorbid subjects without AKI.

Chindarkar NS, Chawla LS, Straseski JA, Jortani SA, Uettwiller-Geiger D, Orr RR, Kellum JA, Fitzgerald RL. Chindarkar NS, et al. Among authors: jortani sa. Clin Chim Acta. 2016 Jan 15;452:32-7. doi: 10.1016/j.cca.2015.10.029. Epub 2015 Nov 10. Clin Chim Acta. 2016. PMID: 26522657 Free article.

10

Validity of unbound digoxin measurements by immunoassays in presence of antidote (Digibind).

Jortani SA, Pinar A, Johnson NA, Valdes R Jr. Jortani SA, et al. Clin Chim Acta. 1999 May;283(1-2):159-69. doi: 10.1016/s0009-8981(99)00043-1. Clin Chim Acta. 1999. PMID: 10404740

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

75 results

Search Page

Filters